KalGene Pharmaceuticals

0 followers


Kalgene is developing a novel fusion protein therapeutic for slowing the progression of Alzheimer’s disease, with technology licensed from the National Research Council of Canada.

Industries

Headquarters

Montreal, Canada

Employees

1-10

Links

Org chart

Nickolay V. Kukekov
President & CEO

Nickolay V. Kukekov

Collapse
Albert Agro
Acting Chief Medical Officer
Guriq S. Basi
Head of Preclinical Studies